Predictive Technology Group Inc PRED
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.05 / $0.07
- Market Cap
- $29,959.68
- Volume/Avg
- 2,500 / 57,781
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Predictive Technology Group Inc (PRx) is a biotechnology company. It develops, commercializes, acquires and invests in technologies engaged in novel molecular diagnostic and therapeutic products in healthcare. The HCT/P segment offers minimally manipulated tissue products intended for homologous use, prepared utilizing proprietary extraction methods that reduce the loss of important scaffolding, growth factors and cytokines. The company's Diagnostics and Therapeutics segment uses data analytics for disease identification and subsequent therapeutic intervention through novel gene-based diagnostics, and companion therapeutics. It generates most of its revenues from HCT/Ps segment.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 64
- Website
- https://www.predtechgroup.com
Valuation
|
Metric
|
PRED
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
PRED
|
|---|---|
Quick Ratio | 0.08 |
Current Ratio | 0.29 |
Interest Coverage | −64.70 |
Quick Ratio
PRED
Profitability
|
Metric
|
PRED
|
|---|---|
Return on Assets (Normalized) | −32.13% |
Return on Equity (Normalized) | −50.64% |
Return on Invested Capital (Normalized) | −41.32% |
Return on Assets
PRED
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk A/S ADR
NVO
| Cjlhxsrh | Cmwl | $565.6 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Zrqghsqdt | Pywyxjc | $127.8 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Xbnllqgq | Pcvbxk | $118.7 Bil | |||
| Moderna Inc
MRNA
| Hjmgwkph | Pgcqy | $46.8 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Tzpjzpvdv | Chzgzc | $29.7 Bil | |||
| argenx SE ADR
ARGX
| Zksmpzbx | Kpxv | $29.3 Bil | |||
| BioNTech SE ADR
BNTX
| Qvfmhwzzn | Zpvd | $20.7 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Qbwrqjrv | Fxpvsj | $16.1 Bil | |||
| United Therapeutics Corp
UTHR
| Fcdtsxn | Vxggt | $15.0 Bil | |||
| Incyte Corp
INCY
| Mccrykjj | Cnmkwnx | $13.5 Bil |